Biogen has announced plans to invest an additional $2bn in Research Triangle Park (RTP) in the US state of North Carolina.

One of North Carolina’s largest life sciences companies, Biogen Inc. (Nasdaq BIIB), is celebrating its 30th anniversary in the state by announcing that it intends to invest an additional $2 billion at ...

Four-year data: On Wednesday, July 30, as part of the “Developing Topics Session: Innovative Therapeutic Approaches” (8:00 – 8:45 AM EDT ), initial four-year findings will be presented on lecanemab ...

RESEARCH TRIANGLE PARK, N.C. (WTVD) -- Global biotechnology firm Biogen announced a major investment in its Research Triangle Park hub. The company said it will spend $2 billion to expand its North ...

The drugmaker has invested $10 billion in Wake and Durham counties over the past 30 years. Biogen says that figure will increase.

Presentations on tau to explore its biological role, the development of targeted therapies and biomarkers, and the future integration of these innovations into clinical practice ...

In February 2025, Biogen Inc. (NASDAQ:BIIB) formed a partnership with Stoke Therapeutics to develop zorevunersen for Dravet ...

This was the stock's second consecutive day of losses.

Biogen Inc. has announced a $2 billion investment to expand its manufacturing capabilities at Research Triangle Park (RTP), ...

The biotech giant will grow its footprint at Research Triangle Park, while Premix opens a life sciences manufacturing plant ...

Biogen Inc. is investing $2 billion in its North Carolina RTP site, expanding manufacturing amid tariff talks.

A higher-dose regimen of nusinersen may provide further benefits to people with SMA relative to the approved regimen, its ...